PressDecember 7, 2020 CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics as Part of its Commitment to Strategic Growth
PressDecember 4, 2020 PsyBio Therapeutics and Leo Acquisitions Announce Closing of CAD$14.5 Million Oversubscribed Private Placement
PressDecember 4, 2020 Field Trip Health Ltd. Provides Operational and Investor Update, Announces Expanded Hours at its Field Trip Health Center in Toronto plus Rollout of Portal, Field Trip’s Proprietary Digital Mental Health Platform
PressDecember 4, 2020 Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific
PressDecember 3, 2020 Epidemiologist Dr. Joel Moody Joins Revive Therapeutics as Medical and Clinical Advisor
PressDecember 2, 2020 CaaMTech Collaborates With the Leibniz Institute for Natural Product Research to Investigate Psychedelic Mushrooms
PressDecember 2, 2020 Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial
PressNovember 30, 2020 Field Trip Health Ltd. Reports Second Fiscal Quarter 2021 Financial Results, Announces Two New Field Trip Health Center Locations
PressNovember 30, 2020 New Wave: Enters into Partnership with the University of West Indies, Mona, Jamaica for Medicinal Drug Discovery
PressNovember 24, 2020 MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines
PressNovember 23, 2020 PharmaDrug Positions for Eurozone Psychedelic Distribution as Germany Begins Psilocybin Depression Study
PressNovember 20, 2020 Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market
PressNovember 19, 2020 Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health
PressNovember 19, 2020 NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss – Better Plant Sciences
PressNovember 18, 2020 Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics
PressNovember 17, 2020 Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program
PressNovember 16, 2020 MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities
PressNovember 13, 2020 Entheon Biomedical Corp. Commences Trading on the Canadian Securities Exchange
